ACTIVE

European Medical Solutions

Financial year 2025 · Closed on 31/12/2025

Net result338,5 k €+101,0 %over 1 year

Revenue606,6 k €

Equity45,9 M €+0,7 %over 1 year

Identity

Source · BCE/KBO

European Medical Solutions is a Public limited company incorporated in 1997. Its main activity is: Manufacture of other chemical products n.e.c.. Its registered office is in Ixelles.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0460.798.795
Incorporation: 05/06/1997
Legal form: Public limited company
Registered office: Avenue Louise 231
1050 Ixelles · BruxellesSee on map
Contributed capital: 104 701 717,00 €
Latest accounts: 31/12/2025

Activities (NACE)

20590Manufacture of other chemical products n.e.c.· main 20590Manufacture of other chemical products n.e.c.24660Manufacture of basic metals 72109Research and experimental development on natural sciences and engineering 72190Other research and experimental development on natural sciences and engineering 73100Advertising+3

Joint committees (1)

Contacts

2 public details availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflow

Financials

Source · NBB, 25 filings

Trend over 16 financial years

	2025		2024		2023		2020		2019
Income statement
Revenue	606,6 k €		–		–		–		–
EBITDA	-113,3 k €	+67.5%	-348,9 k €	-20.8%	-288,9 k €	+70.3%	-973,3 k €	+63.8%	-2,7 M €
Operating result	-113,3 k €	-370%	42 k €	+115%	-288,9 k €	+73.6%	-1,1 M €	+94.0%	-18,2 M €
Net result	338,5 k €	+101%	168,4 k €	+928%	-20,3 k €	+98.4%	-1,3 M €	+92.9%	-17,7 M €
Balance sheet
Equity	45,9 M €	+0.7%	45,6 M €	+0.4%	45,4 M €	+918%	-5,6 M €	-30.1%	-4,3 M €
Total assets	46,7 M €	+0.4%	46,5 M €	-1.2%	47,1 M €	+806%	5,2 M €	-25.4%	7 M €
Cash	376,8 k €	+696%	47,3 k €	-88.7%	420,2 k €	-85.3%	2,9 M €	-21.9%	3,6 M €
Debts	802,2 k €	-15.3%	946,9 k €	-25.4%	1,3 M €	-88.0%	10,6 M €	-4.4%	11,1 M €
Other
Workforce	–		–		–		2,7 ETP	-83.5%	16,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 31 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Julien Delpech	Director12/06/2025 → 14/06/2029
Samuel SANCERNI	Managing director12/06/2025 → 14/06/2029Afgevaardigd Bestuurder24/01/2022 → 15/06/2025ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Marie-Laurence BORIE	Director08/06/2023 → 15/06/2026
Jean-François GENDRON	Chairman of the board of directors12/09/2022 → 15/06/2026

Other companies at this address

Avenue Louise 231 1050 Ixelles

Company	CBE no.
2CRSi Belgium● Active	0757.849.320
3B POSTERITY● Active	0878.258.190
4SIGHT● Active	0876.943.940
ABIS The academy of Business in Society● Active	0479.819.507
ABRIDA● Active	0450.539.858
ACCORD HEALTHCARE● Active	0841.940.204
ACeLaw● Active	0716.861.870
ACK INVEST● Active	0717.757.240
ACN● Active	0720.885.885
ACTIVE P.A.● Active	0896.003.450
ADO PROJET● Active	1018.453.478
ADRESTIA INVEST● Active	0663.666.971
AEACUS● Active	1003.336.029
AetheraX● Active	1038.601.764
A-FIRST● Active	0407.890.839
AFRICA INTERNATIONAL GROUP● Active	0826.132.667
AI2INNOVATE● Active	1030.081.897
AIRINC EUROPE● Active	0475.554.277
AJPS INVEST● Active	0665.721.688
AKIS.STUDIO● Active	1035.515.679

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	10/07/2026	01/08/2025	04/04/2025	10/07/2023	28/09/2022	29/11/2021
General meeting	11/06/2026	12/06/2025	13/06/2024	08/06/2023	12/09/2022	10/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 25 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	11/06/2026	10/07/2026	French	PDF
Full model	31/12/2024	12/06/2025	01/08/2025	French	PDF
Full modelCorrection	31/12/2023	13/06/2024	04/04/2025	French	PDF
Full model	31/12/2023	13/06/2024	30/07/2024	French	PDF
Full model	31/12/2022	08/06/2023	10/07/2023	French	PDF
Full model	31/12/2021	12/09/2022	28/09/2022	French	PDF
Full modelCorrection	31/12/2020	10/06/2021	29/11/2021	French	PDF
Full modelCorrection	31/12/2020	10/06/2021	15/10/2021	French	PDF
Full model	31/12/2020	10/06/2021	30/06/2021	French	PDF
Full model	31/12/2019	11/06/2020	09/07/2020	French	PDF
Full model	31/12/2018	13/06/2019	10/07/2019	French	PDF
Full model	31/12/2017	14/06/2018	02/07/2018	French	PDF
Full model	31/12/2016	08/06/2017	27/06/2017	French	PDF
Full model	31/12/2015	30/06/2016	27/07/2016	French	PDF
Abridged model	31/12/2014	11/06/2015	09/07/2015	French	PDF
Abridged model	31/12/2013	12/06/2014	11/08/2014	French	PDF
Abridged modelCorrection	31/12/2012	13/06/2013	13/08/2013	French	PDF
Abridged model	31/12/2012	13/06/2013	01/07/2013	French	PDF
Abridged model	31/12/2011	14/06/2012	16/07/2012	French	PDF
Abridged modelCorrection	31/12/2010	09/06/2011	15/11/2011	French	PDF
Abridged model	31/12/2010	09/06/2011	28/07/2011	French	PDF
Abridged model	31/12/2009	10/06/2010	18/08/2010	French	PDF
Abridged model	31/12/2008	11/06/2009	18/08/2009	French	PDF
Abridged model	31/12/2007	30/07/2008	13/08/2008	French	PDF
Abridged model	31/12/2006	29/06/2007	23/07/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 31 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Julien Delpech	Director12/06/2025 → 14/06/2029
Samuel SANCERNI	Managing director12/06/2025 → 14/06/2029Afgevaardigd Bestuurder24/01/2022 → 15/06/2025ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Marie-Laurence BORIE	Director08/06/2023 → 15/06/2026
Jean-François GENDRON	Chairman of the board of directors12/09/2022 → 15/06/2026

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates09/07/2026
Renouvellement du mandat de deux administrateurs
PDF
Mandates24/07/2025
DEMISSIONS, NOMINATIONS
PDF
Other26/02/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DIVERS
PDF
Other06/02/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates19/06/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DENOMINATION
PDF
Mandates03/07/2023
DEMISSIONS, NOMINATIONS
PDF
Other12/06/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates28/09/2022
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings16 filings

Mandates

Samuel SANCERNI

Julien Delpech

Marie-Laurence BORIE

Jean-François GENDRON

Régis ROCHE

SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

NOSHAQ

RE Finance Consulting SA

François MEURGEY

SFH

ZOPAMAVI SAS

Jean-Paul PRIEELS

and 21 more mandates

199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029

European Medical Solutions

Avenue Louise 231, 1050 Ixelles

Managing directorAfgevaardigd Bestuurder

Director

Chairman of the board of directors

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Avenue Louise 231, 1050 IxellesCurrent	accounts 2023 → 2025	Accounts 2025 · 2026-00276995

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
European Medical SolutionsCurrent	accounts 2024 → 2025	Accounts 2025 · 2026-00276995
DMS Imaging	accounts 2023	Accounts 2023 · 2025-00064276

Events

2025
Annual accounts 2025338,5 k €↑
2024
Annual accounts 2024168,4 k €↑
2024
Name changeEuropean Medical Solutions
2023
Annual accounts 2023-20,3 k €↑
2020
Annual accounts 2020-1,3 M €↑
2019
Annual accounts 2019-17,7 M €↓
2018
Annual accounts 2018-15,3 M €↓
2017
Annual accounts 2017-13,1 M €↑
2016
Annual accounts 2016-16 M €↓
2015
Annual accounts 2015-4 M €↓
2014
Annual accounts 2014-1,4 M €↑
2013
Annual accounts 2013-2,3 M €↓
2012
Annual accounts 2012-2,3 M €↑
2011
Annual accounts 2011-3,3 M €↓
2010
Annual accounts 2010-2,7 M €↓
2009
Annual accounts 2009-2,7 M €↓
2008
Annual accounts 2008-1,6 M €
05/06/1997
IncorporationPublic limited company

European Medical Solutions

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events